MISSISSAUGA, ONTARIO--(Marketwire - November 12, 2007) - Covalon Technologies Ltd. (the “Corporation” or “Covalon”) (TSX VENTURE: COV) today announced the launch of BIOSTEP™ and BIOSTEP Ag, the latest products using its proprietary collagen technology for the treatment of chronic wounds. The products were introduced by Covalon’s commercial partner Smith & Nephew’s (NYSE: SNN)(LSE: SN) Advanced Wound Management division, at the Clinical Symposium in Advanced Wound Care in Nashville, Tennessee, on October 11, 2007.
